Titan Biotech, a company in the Specialty Chemicals industry, reported revenue of ₹76 crore and net profit of ₹13 crore for the September 2026 quarter.
Titan Biotech (BSE: TITANBIO) closed at ₹381.10 on 20 Nov 2026, up 100.3% over the past year. Its market capitalisation is ₹1,968 crore and it trades at 50.9 times earnings.
Incorporated in 1992, Titan Biotech Ltd manufacturer and exporter of the Biological products
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.